To view this email as a web page, click here.
 
TOP STORIES
 
Pharmaceutical pipeline: Top 4 conditions to watch
Although drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Read more
 
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy Summit
The conference raised important points about value-based contracts and the specialty pharmacy space.
Read more
 
Incremental clinical advances for Duchenne Muscular Dystrophy
Advances in the understanding of Duchenne Muscular Dystrophy's genetic and molecular underpinnings offer hope that gene therapies might one day help.
Read more
 
DIGITAL EDITION
Check out our latest issue featuring
 • Skyrocketing pharmaceutical costs: MCOs fight back
 • Imitation-worthy palliative care programs
 • Managed care pharmacy survey
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.